Scientists from the Jules Bordet Institute and the University of Liège develop a predictive biomarker for a rare form of leukemia
New biomarker predicts the onset of aggressive leukemia years before symptoms appear
New biomarker predicts the onset of aggressive leukemia years before symptoms appear
This clinical study StereoBed is coordinated within the Jules Bordet Institute
La magie de fin d’année revient à l’Institut du 08 au 12/12/2025 (10h - 17h)
Department :
Nuclear medicine
Department :
Nuclear medicine
, Medical Physics
Speciality : Radiophysician
Department :
Nuclear medicine
Department :
Nuclear medicine
Department :
Nuclear medicine
Department :
Nuclear medicine
Department :
Mediation
+32 (0)2 541 35 11
Department :
Nuclear medicine
Pr. F. Meunier and Pr. JP Sculier : Atelier Marcel Hastir
In vieuw of the news : « COVID-19 » by Pr. Aoun
Annulation of the seminar
Les défis et opportunités des dons de tissus post-mortem dans le contexte de la recherche sur le cancer.
Centres du cancer : ce que l’Europe nous prépare. (Dr JB Burrion, Institut Bordet)
Economie de santé et droits des patients (Alain de Wever, ULB)
Determination of new clinico-pathological pronostic factors in patients with colorectal and ovarian peritoneal mestastases. Dr Antoine El Asmar, Prof. Gabriel Liberale, Chirurgie des Tumeurs Abdominales, IJB.
8 + 9/10/2020 : Annulation of the 6th Human Cancer Immunology Course (postponed in 2021)
Prof. AP Meert (Service des soins intensifs et urgences oncologiques & oncologie thoracique